生物技术公司BioNTech(BNTX.US)盘初跌超6%,报104.7美元。消息面上,知情人士透露,辉瑞寻求出售其在COVID-19疫苗合作伙伴BioNTech的全部剩余股权。此次股权出售预计将为辉瑞带来至多约5.08亿美元收益。BioNTech则表示,与辉瑞的合作没有改变,不会对辉瑞的任何资本市场活动发表评论。(格隆汇)
生物技术公司BioNTech(BNTX.US)盘初跌超6%,报104.7美元。消息面上,知情人士透露,辉瑞寻求出售其在COVID-19疫苗合作伙伴BioNTech的全部剩余股权。此次股权出售预计将为辉瑞带来至多约5.08亿美元收益。BioNTech则表示,与辉瑞的合作没有改变,不会对辉瑞的任何资本市场活动发表评论。(格隆汇)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.